Home Mf Research Lic Mf Healthcare Fund Regular Plan Growth
LIC MUTUAL FUND

Mutual Fund Research

LIC MF Healthcare Fund - Regular Plan - Growth

Fund Performance

-
-
Historical NAV
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • SI

SIP Returns

Historical performance of a ₹1,000 monthly SIP

Historical data
Investment Period SIP Start Date Amount Invested Current Value Absolute Return
One Week 2026-10-27 ₹1,000.00 ₹1,031.68 +3.17%
Two Week 2026-10-19 ₹1,000.00 ₹1,053.04 +5.30%
One Month 2026-10-05 ₹1,000.00 ₹1,013.02 +1.30%
Three Months 2026-08-05 ₹3,000.00 ₹2,972.32 -0.92%
Six Months 2026-05-07 ₹6,000.00 ₹6,146.96 +2.45%
One Year 2025-11-03 ₹12,000.00 ₹13,121.01 +9.34%
Three Year 2023-11-06 ₹36,000.00 ₹43,517.44 +20.88%
Five Year 2021-11-08 ₹60,000.00 ₹89,296.60 +48.83%
Since Inception 2019-02-28 ₹94,000.00 ₹174,916.70 +86.08%

Past returns are historical, not guaranteed. SIP values depend on the dates and NAVs used.

Return Calculator

Explore SIP and one-time investment scenarios

₹1,000₹50,000
Investment Duration

Projection uses the selected fund return as an annualized assumption. It does not predict future performance.

Estimated Investment Summary

Investment
₹0
Maturity Value
₹0
Abs. Returns
₹0
Assumed Annual Return
0%

Illustrative values only. Market returns are not fixed or guaranteed.

Portfolio Allocation

Explore asset allocation, sector exposure and company holdings.

Equity
N/A
Debt
N/A
Others
N/A

Sector Allocation

Distribution across different sectors

Pharmaceuticals & Biotechnology 61.34%
Healthcare Services 31.21%
Chemicals & Petrochemicals 4.98%
Other 2.47%

Top Holdings

Company-wise portfolio exposure

Sun Pharmaceutical Industries Ltd. 9.59%
Divi's Laboratories Ltd. 9.07%
Neuland Laboratories Ltd. 6.14%
Torrent Pharmaceuticals Ltd. 6.04%
Apollo Hospitals Enterprise Ltd. 5.75%
Aurobindo Pharma Ltd. 5.23%
Navin Fluorine International Ltd. 4.98%
Zydus Lifesciences Ltd. 4.97%
Aster DM Quality Care Ltd. 4.61%
Fortis Healthcare Ltd. 3.77%
Metropolis Healthcare Ltd. 3.35%
Gland Pharma Ltd. 3.20%
Mankind Pharma Ltd. 3.11%
Nephrocare Health Services Ltd. 3.05%
Max Healthcare Institute Ltd. 2.99%
Cohance Lifesciences Ltd. 2.95%
Glenmark Pharmaceuticals Ltd. 2.61%
Global Health Ltd. 2.59%
Dr Agarwal's Health Care Ltd. 2.46%
Biocon Ltd. 2.37%
IPCA Laboratories Ltd. 2.33%
Onesource Specialty Pharma Ltd. 2.30%
Piramal Pharma Ltd. 1.43%
Syngene International Ltd. 1.38%
Artemis Medicare Services Ltd. 1.26%
Treps 2.57%
Net Receivables / (Payables) -0.10%

Risk Ratios & Analysis

Understand the fund’s volatility, benchmark exposure and redemption characteristics.

σ
Standard Deviation
16.37%
Return volatility
β
Beta
0.92
Benchmark sensitivity
S
Sharpe Ratio
0.85
Risk-adjusted return
↗
Lock-in Period
N/A
Redemption restriction
◷
Residual Maturity
N/A
Time to maturity

Scheme Riskometer

Published risk classification for this scheme

Principal risk level

Investors understand that their principal will be at

Very High Risk

Low
Low to Moderate
Moderate
Moderately High
High
Very High

Riskometer is a scheme risk classification, not a prediction of future performance.

Fund Family

Compare schemes from LIC MUTUAL FUND by performance, fundamentals and risk.

Returns are historical and do not guarantee future performance.

View All LIC MUTUAL FUND Funds

Scheme Objective

The investment mandate and purpose of this scheme

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.

Scheme Details

Investment requirements and key fund information

Fund Information

Min. SIP Amount
N/A
Min. Lumpsum Amount
N/A
AUM (in Cr.)
N/A
Expense Ratio (Regular)
2.67%
Expense Ratio (Direct)
1.37%
Lock-in Period
N/A
Fund Age
N/A
Benchmark
BSE Healthcare- TRI

Exit Load

Charges that may apply when you redeem units

Nil, If units of the Scheme are redeemed or switched out up to 12% of the units (the limit) within 90 days from the date of allotment. 1% of the applicable NAV, If units of the scheme are redeemed or switched out in excess of the limit within 90 days from the date of allotment. Nil, If units of scheme are redeemed or switched out after 90 days from the date of allotment.

FAQs

Is a Mutual Fund with a Lower NAV Better?

What Are the Charges in Mutual Fund Investments?

What Are the Tax Benefits of Mutual Funds?

Is It a Good Time to Invest in Mutual Funds?

What Is the Difference Between Dividend and Growth Plans?

Should I Invest in Infrastructure Funds?

What Are Sector-Specific Funds/Schemes?

What Happens If I Miss an SIP Payment?

How Can I Compare Different Mutual Funds?